Global Companion Diagnostic Tests in Oncology Market 2024 by Company, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Companion Diagnostic Tests in Oncology market size was valued at USD 4012 million in 2023 and is forecast to a readjusted size of USD 7377.3 million by 2030 with a CAGR of 9.1% during review period.
Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Companion Diagnostic Tests in Oncology industry chain, the market status of Pharmaceutical & Biotechnology Companies (Protein Detection, DNA Detection), Medical Device Companies (Protein Detection, DNA Detection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Diagnostic Tests in Oncology.
Regionally, the report analyzes the Companion Diagnostic Tests in Oncology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Diagnostic Tests in Oncology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Companion Diagnostic Tests in Oncology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Diagnostic Tests in Oncology industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Protein Detection, DNA Detection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Diagnostic Tests in Oncology market.
Regional Analysis: The report involves examining the Companion Diagnostic Tests in Oncology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Diagnostic Tests in Oncology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Companion Diagnostic Tests in Oncology:
Company Analysis: Report covers individual Companion Diagnostic Tests in Oncology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Diagnostic Tests in Oncology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical & Biotechnology Companies, Medical Device Companies).
Technology Analysis: Report covers specific technologies relevant to Companion Diagnostic Tests in Oncology. It assesses the current state, advancements, and potential future developments in Companion Diagnostic Tests in Oncology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Diagnostic Tests in Oncology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Companion Diagnostic Tests in Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Chapter 1, to describe Companion Diagnostic Tests in Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Diagnostic Tests in Oncology, with revenue, gross margin and global market share of Companion Diagnostic Tests in Oncology from 2019 to 2024.
Chapter 3, the Companion Diagnostic Tests in Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Diagnostic Tests in Oncology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic Tests in Oncology.
Chapter 13, to describe Companion Diagnostic Tests in Oncology research findings and conclusion.
Increasing incidence of cancer, rising cost burden of cancer treatment, and increasing mortalities due to cancer, are some of the major reasons for increasing demand for new and technologically advanced treatment options, therapies, and drugs for the treatment of cancer.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Companion Diagnostic Tests in Oncology industry chain, the market status of Pharmaceutical & Biotechnology Companies (Protein Detection, DNA Detection), Medical Device Companies (Protein Detection, DNA Detection), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Companion Diagnostic Tests in Oncology.
Regionally, the report analyzes the Companion Diagnostic Tests in Oncology markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Companion Diagnostic Tests in Oncology market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Companion Diagnostic Tests in Oncology market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Companion Diagnostic Tests in Oncology industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Protein Detection, DNA Detection).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Companion Diagnostic Tests in Oncology market.
Regional Analysis: The report involves examining the Companion Diagnostic Tests in Oncology market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Companion Diagnostic Tests in Oncology market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Companion Diagnostic Tests in Oncology:
Company Analysis: Report covers individual Companion Diagnostic Tests in Oncology players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Companion Diagnostic Tests in Oncology This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Pharmaceutical & Biotechnology Companies, Medical Device Companies).
Technology Analysis: Report covers specific technologies relevant to Companion Diagnostic Tests in Oncology. It assesses the current state, advancements, and potential future developments in Companion Diagnostic Tests in Oncology areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Companion Diagnostic Tests in Oncology market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Companion Diagnostic Tests in Oncology market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Protein Detection
- DNA Detection
- Pharmaceutical & Biotechnology Companies
- Medical Device Companies
- Research Institutes
- Others
- Abbott
- Roche
- Genomic Health
- QIAGEN
- Agilent
- Agendia
- BioMerieux
- Illumina
- Siemens Healthcare
- Thermo Fisher
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Companion Diagnostic Tests in Oncology product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Companion Diagnostic Tests in Oncology, with revenue, gross margin and global market share of Companion Diagnostic Tests in Oncology from 2019 to 2024.
Chapter 3, the Companion Diagnostic Tests in Oncology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2019 to 2030.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2019 to 2024.and Companion Diagnostic Tests in Oncology market forecast, by regions, type and application, with consumption value, from 2025 to 2030.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Companion Diagnostic Tests in Oncology.
Chapter 13, to describe Companion Diagnostic Tests in Oncology research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic Tests in Oncology by Type
1.3.1 Overview: Global Companion Diagnostic Tests in Oncology Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type in 2023
1.3.3 Protein Detection
1.3.4 DNA Detection
1.4 Global Companion Diagnostic Tests in Oncology Market by Application
1.4.1 Overview: Global Companion Diagnostic Tests in Oncology Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Medical Device Companies
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Companion Diagnostic Tests in Oncology Market Size & Forecast
1.6 Global Companion Diagnostic Tests in Oncology Market Size and Forecast by Region
1.6.1 Global Companion Diagnostic Tests in Oncology Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Companion Diagnostic Tests in Oncology Market Size by Region, (2019-2030)
1.6.3 North America Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.4 Europe Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.6 South America Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Companion Diagnostic Tests in Oncology Product and Solutions
2.1.4 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Companion Diagnostic Tests in Oncology Product and Solutions
2.2.4 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Genomic Health
2.3.1 Genomic Health Details
2.3.2 Genomic Health Major Business
2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Product and Solutions
2.3.4 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genomic Health Recent Developments and Future Plans
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business
2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Product and Solutions
2.4.4 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 QIAGEN Recent Developments and Future Plans
2.5 Agilent
2.5.1 Agilent Details
2.5.2 Agilent Major Business
2.5.3 Agilent Companion Diagnostic Tests in Oncology Product and Solutions
2.5.4 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Agilent Recent Developments and Future Plans
2.6 Agendia
2.6.1 Agendia Details
2.6.2 Agendia Major Business
2.6.3 Agendia Companion Diagnostic Tests in Oncology Product and Solutions
2.6.4 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agendia Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Product and Solutions
2.7.4 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Companion Diagnostic Tests in Oncology Product and Solutions
2.8.4 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Siemens Healthcare
2.9.1 Siemens Healthcare Details
2.9.2 Siemens Healthcare Major Business
2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Solutions
2.9.4 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Siemens Healthcare Recent Developments and Future Plans
2.10 Thermo Fisher
2.10.1 Thermo Fisher Details
2.10.2 Thermo Fisher Major Business
2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Product and Solutions
2.10.4 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Thermo Fisher Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Companion Diagnostic Tests in Oncology by Company Revenue
3.2.2 Top 3 Companion Diagnostic Tests in Oncology Players Market Share in 2023
3.2.3 Top 6 Companion Diagnostic Tests in Oncology Players Market Share in 2023
3.3 Companion Diagnostic Tests in Oncology Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Tests in Oncology Market: Region Footprint
3.3.2 Companion Diagnostic Tests in Oncology Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Tests in Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Tests in Oncology Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
6.2 North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Country
6.3.1 North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
6.3.2 United States Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
6.3.3 Canada Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
6.3.4 Mexico Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
7.2 Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Country
7.3.1 Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
7.3.2 Germany Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.3 France Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.5 Russia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.6 Italy Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2030)
8.3.2 China Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.3 Japan Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.4 South Korea Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.5 India Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.7 Australia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
9.2 South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
9.3 South America Companion Diagnostic Tests in Oncology Market Size by Country
9.3.1 South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
9.3.2 Brazil Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
9.3.3 Argentina Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
10.3.2 Turkey Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10.3.4 UAE Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Tests in Oncology Market Drivers
11.2 Companion Diagnostic Tests in Oncology Market Restraints
11.3 Companion Diagnostic Tests in Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Tests in Oncology Industry Chain
12.2 Companion Diagnostic Tests in Oncology Upstream Analysis
12.3 Companion Diagnostic Tests in Oncology Midstream Analysis
12.4 Companion Diagnostic Tests in Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Companion Diagnostic Tests in Oncology
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Companion Diagnostic Tests in Oncology by Type
1.3.1 Overview: Global Companion Diagnostic Tests in Oncology Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type in 2023
1.3.3 Protein Detection
1.3.4 DNA Detection
1.4 Global Companion Diagnostic Tests in Oncology Market by Application
1.4.1 Overview: Global Companion Diagnostic Tests in Oncology Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Pharmaceutical & Biotechnology Companies
1.4.3 Medical Device Companies
1.4.4 Research Institutes
1.4.5 Others
1.5 Global Companion Diagnostic Tests in Oncology Market Size & Forecast
1.6 Global Companion Diagnostic Tests in Oncology Market Size and Forecast by Region
1.6.1 Global Companion Diagnostic Tests in Oncology Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Companion Diagnostic Tests in Oncology Market Size by Region, (2019-2030)
1.6.3 North America Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.4 Europe Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.6 South America Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Companion Diagnostic Tests in Oncology Market Size and Prospect (2019-2030)
2 COMPANY PROFILES
2.1 Abbott
2.1.1 Abbott Details
2.1.2 Abbott Major Business
2.1.3 Abbott Companion Diagnostic Tests in Oncology Product and Solutions
2.1.4 Abbott Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Abbott Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Companion Diagnostic Tests in Oncology Product and Solutions
2.2.4 Roche Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Roche Recent Developments and Future Plans
2.3 Genomic Health
2.3.1 Genomic Health Details
2.3.2 Genomic Health Major Business
2.3.3 Genomic Health Companion Diagnostic Tests in Oncology Product and Solutions
2.3.4 Genomic Health Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Genomic Health Recent Developments and Future Plans
2.4 QIAGEN
2.4.1 QIAGEN Details
2.4.2 QIAGEN Major Business
2.4.3 QIAGEN Companion Diagnostic Tests in Oncology Product and Solutions
2.4.4 QIAGEN Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 QIAGEN Recent Developments and Future Plans
2.5 Agilent
2.5.1 Agilent Details
2.5.2 Agilent Major Business
2.5.3 Agilent Companion Diagnostic Tests in Oncology Product and Solutions
2.5.4 Agilent Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Agilent Recent Developments and Future Plans
2.6 Agendia
2.6.1 Agendia Details
2.6.2 Agendia Major Business
2.6.3 Agendia Companion Diagnostic Tests in Oncology Product and Solutions
2.6.4 Agendia Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Agendia Recent Developments and Future Plans
2.7 BioMerieux
2.7.1 BioMerieux Details
2.7.2 BioMerieux Major Business
2.7.3 BioMerieux Companion Diagnostic Tests in Oncology Product and Solutions
2.7.4 BioMerieux Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 BioMerieux Recent Developments and Future Plans
2.8 Illumina
2.8.1 Illumina Details
2.8.2 Illumina Major Business
2.8.3 Illumina Companion Diagnostic Tests in Oncology Product and Solutions
2.8.4 Illumina Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Illumina Recent Developments and Future Plans
2.9 Siemens Healthcare
2.9.1 Siemens Healthcare Details
2.9.2 Siemens Healthcare Major Business
2.9.3 Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Solutions
2.9.4 Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Siemens Healthcare Recent Developments and Future Plans
2.10 Thermo Fisher
2.10.1 Thermo Fisher Details
2.10.2 Thermo Fisher Major Business
2.10.3 Thermo Fisher Companion Diagnostic Tests in Oncology Product and Solutions
2.10.4 Thermo Fisher Companion Diagnostic Tests in Oncology Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 Thermo Fisher Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Companion Diagnostic Tests in Oncology Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Companion Diagnostic Tests in Oncology by Company Revenue
3.2.2 Top 3 Companion Diagnostic Tests in Oncology Players Market Share in 2023
3.2.3 Top 6 Companion Diagnostic Tests in Oncology Players Market Share in 2023
3.3 Companion Diagnostic Tests in Oncology Market: Overall Company Footprint Analysis
3.3.1 Companion Diagnostic Tests in Oncology Market: Region Footprint
3.3.2 Companion Diagnostic Tests in Oncology Market: Company Product Type Footprint
3.3.3 Companion Diagnostic Tests in Oncology Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Companion Diagnostic Tests in Oncology Consumption Value and Market Share by Type (2019-2024)
4.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Type (2025-2030)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2024)
5.2 Global Companion Diagnostic Tests in Oncology Market Forecast by Application (2025-2030)
6 NORTH AMERICA
6.1 North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
6.2 North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
6.3 North America Companion Diagnostic Tests in Oncology Market Size by Country
6.3.1 North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
6.3.2 United States Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
6.3.3 Canada Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
6.3.4 Mexico Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7 EUROPE
7.1 Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
7.2 Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
7.3 Europe Companion Diagnostic Tests in Oncology Market Size by Country
7.3.1 Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
7.3.2 Germany Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.3 France Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.5 Russia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
7.3.6 Italy Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8 ASIA-PACIFIC
8.1 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Companion Diagnostic Tests in Oncology Market Size by Region
8.3.1 Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2030)
8.3.2 China Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.3 Japan Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.4 South Korea Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.5 India Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
8.3.7 Australia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
9 SOUTH AMERICA
9.1 South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
9.2 South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
9.3 South America Companion Diagnostic Tests in Oncology Market Size by Country
9.3.1 South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
9.3.2 Brazil Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
9.3.3 Argentina Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Companion Diagnostic Tests in Oncology Market Size by Country
10.3.1 Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2030)
10.3.2 Turkey Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
10.3.4 UAE Companion Diagnostic Tests in Oncology Market Size and Forecast (2019-2030)
11 MARKET DYNAMICS
11.1 Companion Diagnostic Tests in Oncology Market Drivers
11.2 Companion Diagnostic Tests in Oncology Market Restraints
11.3 Companion Diagnostic Tests in Oncology Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Companion Diagnostic Tests in Oncology Industry Chain
12.2 Companion Diagnostic Tests in Oncology Upstream Analysis
12.3 Companion Diagnostic Tests in Oncology Midstream Analysis
12.4 Companion Diagnostic Tests in Oncology Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Diagnostic Tests in Oncology Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Diagnostic Tests in Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Companion Diagnostic Tests in Oncology Product and Solutions
Table 8. Abbott Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Companion Diagnostic Tests in Oncology Product and Solutions
Table 13. Roche Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Genomic Health Company Information, Head Office, and Major Competitors
Table 16. Genomic Health Major Business
Table 17. Genomic Health Companion Diagnostic Tests in Oncology Product and Solutions
Table 18. Genomic Health Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Genomic Health Recent Developments and Future Plans
Table 20. QIAGEN Company Information, Head Office, and Major Competitors
Table 21. QIAGEN Major Business
Table 22. QIAGEN Companion Diagnostic Tests in Oncology Product and Solutions
Table 23. QIAGEN Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. QIAGEN Recent Developments and Future Plans
Table 25. Agilent Company Information, Head Office, and Major Competitors
Table 26. Agilent Major Business
Table 27. Agilent Companion Diagnostic Tests in Oncology Product and Solutions
Table 28. Agilent Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Agilent Recent Developments and Future Plans
Table 30. Agendia Company Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostic Tests in Oncology Product and Solutions
Table 33. Agendia Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Agendia Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux Companion Diagnostic Tests in Oncology Product and Solutions
Table 38. BioMerieux Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. Illumina Company Information, Head Office, and Major Competitors
Table 41. Illumina Major Business
Table 42. Illumina Companion Diagnostic Tests in Oncology Product and Solutions
Table 43. Illumina Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Illumina Recent Developments and Future Plans
Table 45. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 46. Siemens Healthcare Major Business
Table 47. Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Solutions
Table 48. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Siemens Healthcare Recent Developments and Future Plans
Table 50. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 51. Thermo Fisher Major Business
Table 52. Thermo Fisher Companion Diagnostic Tests in Oncology Product and Solutions
Table 53. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Recent Developments and Future Plans
Table 55. Global Companion Diagnostic Tests in Oncology Revenue (USD Million) by Players (2019-2024)
Table 56. Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2019-2024)
Table 57. Breakdown of Companion Diagnostic Tests in Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Companion Diagnostic Tests in Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Companion Diagnostic Tests in Oncology Players
Table 60. Companion Diagnostic Tests in Oncology Market: Company Product Type Footprint
Table 61. Companion Diagnostic Tests in Oncology Market: Company Product Application Footprint
Table 62. Companion Diagnostic Tests in Oncology New Market Entrants and Barriers to Market Entry
Table 63. Companion Diagnostic Tests in Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Companion Diagnostic Tests in Oncology Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Type (2019-2024)
Table 66. Global Companion Diagnostic Tests in Oncology Consumption Value Forecast by Type (2025-2030)
Table 67. Global Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024)
Table 68. Global Companion Diagnostic Tests in Oncology Consumption Value Forecast by Application (2025-2030)
Table 69. North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Companion Diagnostic Tests in Oncology Raw Material
Table 100. Key Suppliers of Companion Diagnostic Tests in Oncology Raw Materials
Table 1. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Companion Diagnostic Tests in Oncology Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Companion Diagnostic Tests in Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Abbott Company Information, Head Office, and Major Competitors
Table 6. Abbott Major Business
Table 7. Abbott Companion Diagnostic Tests in Oncology Product and Solutions
Table 8. Abbott Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Abbott Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Companion Diagnostic Tests in Oncology Product and Solutions
Table 13. Roche Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Roche Recent Developments and Future Plans
Table 15. Genomic Health Company Information, Head Office, and Major Competitors
Table 16. Genomic Health Major Business
Table 17. Genomic Health Companion Diagnostic Tests in Oncology Product and Solutions
Table 18. Genomic Health Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Genomic Health Recent Developments and Future Plans
Table 20. QIAGEN Company Information, Head Office, and Major Competitors
Table 21. QIAGEN Major Business
Table 22. QIAGEN Companion Diagnostic Tests in Oncology Product and Solutions
Table 23. QIAGEN Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. QIAGEN Recent Developments and Future Plans
Table 25. Agilent Company Information, Head Office, and Major Competitors
Table 26. Agilent Major Business
Table 27. Agilent Companion Diagnostic Tests in Oncology Product and Solutions
Table 28. Agilent Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Agilent Recent Developments and Future Plans
Table 30. Agendia Company Information, Head Office, and Major Competitors
Table 31. Agendia Major Business
Table 32. Agendia Companion Diagnostic Tests in Oncology Product and Solutions
Table 33. Agendia Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Agendia Recent Developments and Future Plans
Table 35. BioMerieux Company Information, Head Office, and Major Competitors
Table 36. BioMerieux Major Business
Table 37. BioMerieux Companion Diagnostic Tests in Oncology Product and Solutions
Table 38. BioMerieux Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. BioMerieux Recent Developments and Future Plans
Table 40. Illumina Company Information, Head Office, and Major Competitors
Table 41. Illumina Major Business
Table 42. Illumina Companion Diagnostic Tests in Oncology Product and Solutions
Table 43. Illumina Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Illumina Recent Developments and Future Plans
Table 45. Siemens Healthcare Company Information, Head Office, and Major Competitors
Table 46. Siemens Healthcare Major Business
Table 47. Siemens Healthcare Companion Diagnostic Tests in Oncology Product and Solutions
Table 48. Siemens Healthcare Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Siemens Healthcare Recent Developments and Future Plans
Table 50. Thermo Fisher Company Information, Head Office, and Major Competitors
Table 51. Thermo Fisher Major Business
Table 52. Thermo Fisher Companion Diagnostic Tests in Oncology Product and Solutions
Table 53. Thermo Fisher Companion Diagnostic Tests in Oncology Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. Thermo Fisher Recent Developments and Future Plans
Table 55. Global Companion Diagnostic Tests in Oncology Revenue (USD Million) by Players (2019-2024)
Table 56. Global Companion Diagnostic Tests in Oncology Revenue Share by Players (2019-2024)
Table 57. Breakdown of Companion Diagnostic Tests in Oncology by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Companion Diagnostic Tests in Oncology, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 59. Head Office of Key Companion Diagnostic Tests in Oncology Players
Table 60. Companion Diagnostic Tests in Oncology Market: Company Product Type Footprint
Table 61. Companion Diagnostic Tests in Oncology Market: Company Product Application Footprint
Table 62. Companion Diagnostic Tests in Oncology New Market Entrants and Barriers to Market Entry
Table 63. Companion Diagnostic Tests in Oncology Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Companion Diagnostic Tests in Oncology Consumption Value (USD Million) by Type (2019-2024)
Table 65. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Type (2019-2024)
Table 66. Global Companion Diagnostic Tests in Oncology Consumption Value Forecast by Type (2025-2030)
Table 67. Global Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024)
Table 68. Global Companion Diagnostic Tests in Oncology Consumption Value Forecast by Application (2025-2030)
Table 69. North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 70. North America Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 71. North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 72. North America Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 73. North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 74. North America Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 75. Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 76. Europe Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 77. Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 78. Europe Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 79. Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 80. Europe Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 81. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 82. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 83. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 84. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 85. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2019-2024) & (USD Million)
Table 86. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value by Region (2025-2030) & (USD Million)
Table 87. South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 88. South America Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 89. South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 90. South America Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 91. South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 92. South America Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 93. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2019-2024) & (USD Million)
Table 94. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Type (2025-2030) & (USD Million)
Table 95. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2019-2024) & (USD Million)
Table 96. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Application (2025-2030) & (USD Million)
Table 97. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2019-2024) & (USD Million)
Table 98. Middle East & Africa Companion Diagnostic Tests in Oncology Consumption Value by Country (2025-2030) & (USD Million)
Table 99. Companion Diagnostic Tests in Oncology Raw Material
Table 100. Key Suppliers of Companion Diagnostic Tests in Oncology Raw Materials
LIST OF FIGURES
Figure 1. Companion Diagnostic Tests in Oncology Picture
Figure 2. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type in 2023
Figure 4. Protein Detection
Figure 5. DNA Detection
Figure 6. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical & Biotechnology Companies Picture
Figure 9. Medical Device Companies Picture
Figure 10. Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Companion Diagnostic Tests in Oncology Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Companion Diagnostic Tests in Oncology Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Companion Diagnostic Tests in Oncology Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region in 2023
Figure 17. North America Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2023
Figure 23. Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Companion Diagnostic Tests in Oncology Market Share in 2023
Figure 25. Global Top 6 Players Companion Diagnostic Tests in Oncology Market Share in 2023
Figure 26. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Type (2019-2024)
Figure 27. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2025-2030)
Figure 28. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Application (2019-2024)
Figure 29. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2025-2030)
Figure 30. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 40. France Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region (2019-2030)
Figure 47. China Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 50. India Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 64. Companion Diagnostic Tests in Oncology Market Drivers
Figure 65. Companion Diagnostic Tests in Oncology Market Restraints
Figure 66. Companion Diagnostic Tests in Oncology Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Companion Diagnostic Tests in Oncology in 2023
Figure 69. Manufacturing Process Analysis of Companion Diagnostic Tests in Oncology
Figure 70. Companion Diagnostic Tests in Oncology Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
Figure 1. Companion Diagnostic Tests in Oncology Picture
Figure 2. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type in 2023
Figure 4. Protein Detection
Figure 5. DNA Detection
Figure 6. Global Companion Diagnostic Tests in Oncology Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application in 2023
Figure 8. Pharmaceutical & Biotechnology Companies Picture
Figure 9. Medical Device Companies Picture
Figure 10. Research Institutes Picture
Figure 11. Others Picture
Figure 12. Global Companion Diagnostic Tests in Oncology Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 13. Global Companion Diagnostic Tests in Oncology Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 14. Global Market Companion Diagnostic Tests in Oncology Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 15. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region (2019-2030)
Figure 16. Global Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region in 2023
Figure 17. North America Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 18. Europe Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 19. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 20. South America Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 21. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 22. Global Companion Diagnostic Tests in Oncology Revenue Share by Players in 2023
Figure 23. Companion Diagnostic Tests in Oncology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 24. Global Top 3 Players Companion Diagnostic Tests in Oncology Market Share in 2023
Figure 25. Global Top 6 Players Companion Diagnostic Tests in Oncology Market Share in 2023
Figure 26. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Type (2019-2024)
Figure 27. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Type (2025-2030)
Figure 28. Global Companion Diagnostic Tests in Oncology Consumption Value Share by Application (2019-2024)
Figure 29. Global Companion Diagnostic Tests in Oncology Market Share Forecast by Application (2025-2030)
Figure 30. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 31. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 32. North America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 33. United States Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 34. Canada Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 35. Mexico Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 36. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 37. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 38. Europe Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 39. Germany Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 40. France Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 41. United Kingdom Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 42. Russia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 43. Italy Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 44. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 45. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 46. Asia-Pacific Companion Diagnostic Tests in Oncology Consumption Value Market Share by Region (2019-2030)
Figure 47. China Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 48. Japan Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 49. South Korea Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 50. India Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 51. Southeast Asia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 52. Australia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 53. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 54. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 55. South America Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 56. Brazil Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 57. Argentina Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 58. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Type (2019-2030)
Figure 59. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Application (2019-2030)
Figure 60. Middle East and Africa Companion Diagnostic Tests in Oncology Consumption Value Market Share by Country (2019-2030)
Figure 61. Turkey Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 62. Saudi Arabia Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 63. UAE Companion Diagnostic Tests in Oncology Consumption Value (2019-2030) & (USD Million)
Figure 64. Companion Diagnostic Tests in Oncology Market Drivers
Figure 65. Companion Diagnostic Tests in Oncology Market Restraints
Figure 66. Companion Diagnostic Tests in Oncology Market Trends
Figure 67. Porters Five Forces Analysis
Figure 68. Manufacturing Cost Structure Analysis of Companion Diagnostic Tests in Oncology in 2023
Figure 69. Manufacturing Process Analysis of Companion Diagnostic Tests in Oncology
Figure 70. Companion Diagnostic Tests in Oncology Industrial Chain
Figure 71. Methodology
Figure 72. Research Process and Data Source
